Strides Pharma Science Limited (BOM:532531)
India · Delayed Price · Currency is INR 1,100.05
+12.30 (1.13%)
At close: Oct 7, 2026
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 101.48 billion as of October 7, 2026. Its market cap has increased by 32.00% in one year.
Market Cap
101.48B
Enterprise Value
117.44B
Revenue
50.04B
Global Rank
n/a
Country Rank
n/a
PE Ratio
16.36
ChartMarket Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 101.48B, an increase of 1,254.20%. That is a compound annual growth rate of 10.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 101.48B | 22.29% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |
| Jubilant Pharmova | 158.49B |
| AstraZeneca Pharma India | 150.76B |
| Viyash Scientific | 101.17B |
| Procter & Gamble Health | 89.04B |
| Morepen Laboratories | 73.26B |
| Bliss GVS Pharma | 72.75B |